Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2025-12-28 @ 7:49 PM
Study NCT ID:
NCT00702403
Status:
COMPLETED
Last Update Posted:
2017-08-10
First Post:
2008-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08-14
Start Date Type:
ACTUAL
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-19
First Submit QC Date:
None
Study First Post Date:
2008-06-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-25
Results First Submit QC Date:
None
Results First Post Date:
2017-05-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-11
Last Update Post Date:
2017-08-10
Last Update Post Date Type:
ACTUAL